Actos Bladder Cancer Lawsuit Alleges Drug’s Warnings Were Inadequate

A woman from Fresno, California who took the drug Actos for 8 years has filed suit in California Superior Court alleging the type 2 diabetes drug caused her to develop bladder cancer. The Plaintiff, who is being represented by Gilman Law LLP, a national law firm representing individuals with Actos injuries, continued taking Actos for two years after her bladder cancer diagnoses, and claims that Takeda Pharmaceuticals and other Defendants failed to provide adequate warnings about the drug’s life-threatening side effects.


Actos Lawsuit National Claims Center

Actos Lawsuit National Claims Center

Actos was approved for type 2 diabetes in 1999, and became the best-selling diabetes medication in the world. But in June 2011, the U.S. Food & Drug Administration (FDA) issued a Drug Safety Communication warning that using Actos for more than one year may be associated with an increased risk of bladder cancer. Among other things, the FDA warned that patients with active bladder cancer should not take Actos. The Plaintiff, who began taking Actos sometime around November 5, 2003, was found to have developed cancerous tumors of the bladder on April 29, 2009. According to the complaint, she continued to use Actos until around November 2011, when she became aware of the danger posed by the medication.

File a Claim | Actos Lawsuit National Claims Center

About the Actos Bladder Cancer Lawsuit

The complaint alleges that prior to the drug’s approval, Takeda Pharmaceuticals and other Defendants possessed animal studies and other evidence which they should have known was a signal that bladder cancer risk needed to be further studied before Actos could be placed on the market. The lawsuit further alleges that bladder cancer evidence from human clinical trials became known to the Defendants in the early 2000s. The Plaintiff claims that had she been adequately warned about the potentially life-threatening side effects of Actos, she would have never used the medication.

Actos has been the subject of a growing number of lawsuits since the FDA’s June 2011 warning. A recent Bloomberg report speculated that Takeda could ultimately face as many as 10,000 Actos bladder cancer lawsuits. In anticipation of such a massive litigation, federally filed Actos lawsuits have been consolidated in the U.S. District Court, Western District of Louisiana. The first trials have been scheduled to start in November 2014.

How to File an Actos Claim or Actos Lawsuit

Gilman Law LLP is still offering free legal consultations to Actos users who developed bladder cancer during or following treatment with the drug. To ensure the statute of limitations on their claim does not run out, potential plaintiffs should contact the firm immediately.

IMPORTANT: Once the statute of limitations expires, Actos victims who haven’t filed suit will be unable to recover damages for their injuries.

Free consultations are available by completing our Free Actos Lawsuit Consultation Form online, or call Toll Free at (888) 252-0048.
 

This entry was posted in Drug Defect Lawsuits and tagged , , , , , , , , . Bookmark the permalink.

Awards & Recognition

Gilman Law LLP and its attorneys have been recognized by the leading legal publications and are listed in:


Avvo Rating
Life Member, Multi-Million Dollar Advocates Forum
Life Member, Million Dollar Advocates Forum
Super Lawyers
Lexis Nexis
LawDragon
Association of Trial Lawyers of America
Massachusetts Association of Woman's Lawyers
American Association of Justice: Leaders Forum
American Bar Association and Member of the ABA Antitrust and Litigation Sections and Forum on Franchising and Litigation Section
Public Investors Arbitration Bar Association